Skip to content

Funding success for the Maridulu Budyari Gumal - SPHERE Cancer Clinical Academic Group

The NSW Government through the Cancer Institute NSW has awarded SPHERE's Professor Geoff Delaney a $7M Translational Cancer Research Capacity Building Grant to build capacity and education across the SPHERE Cancer Clinical Academic Group. Commencing on 1 July, the 5 year program will enhance the volume of cancer research the CAG produces, but also to accelerate research translation; ensure succession planning by enhancing career development opportunities; and continue to stimulate high-quality, multidisciplinary, multi-institutional, innovative, impactful research.

Early/mid-career cancer researchers awarded Cancer Clinical Academic Group seed grants

Maridulu Budyari Gumal (SPHERE) Cancer Clinical Academic Group has committed $100,000 in new seed grants for two interdisciplinary projects led by early/mid-career researchers (EMCRs) to be undertaken in 2021.

Congratulations to the successful awardees and their teams.

New liquid biopsies could provide hope for brain cancer patients

Increasing the efficacy of brain cancer treatment traditionally requires access to tissue samples that can shed light on a tumour’s genetic makeup. But, with many malignancies buried deep inside essential areas of the brain, this tissue is often impossible to reach.

A new research project led by Associate Professor Therese Becker of the Ingham Institute is aiming to solve this problem. Using ‘liquid biopsies’ – that is, blood tests – the researchers hope to reveal critical information about individual patient tumours. 

New directions towards a better future for patients with pancreatic cancer

A partnership between the Pancreatic Cancer Research Hub (PCRH) and the Molecular Screening and Therapeutics (MoST) trial in Sydney could help improve the poor survival rates of pancreatic cancer. 

Exploring how to commercialise medical technology

At a recent Medical Technology Workshop, experts shared their perspectives on the challenges of bringing ideas to commercial and clinical fruition - exploring all aspects of medical technology development and commercialisation.

Raising the consumer and community voice

The Cancer Clinical Academic Group Management Committee has increased its consumer and community membership to three people. This recent change acknowledges the value of different perspectives and how lived experiences can strengthen the quality and relevance of health and medical research.